Gerry McKenzie

Corporate Officer/Principal en AERIE PHARMACEUTICALS, INC. .

Health Technology

Perfil

Gerry McKenzie is currently the Vice President-Commercial Operations at Aerie Pharmaceuticals, Inc. He previously worked as the Chief Information Officer at AEON Biopharma Sub, Inc.

Cargos activos de Gerry McKenzie

Empresas	Cargo	Inicio
AERIE PHARMACEUTICALS, INC.	Corporate Officer/Principal	-

Todos los cargos activos de Gerry McKenzie

Antiguos cargos conocidos de Gerry McKenzie.

Empresas	Cargo	Fin
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Chief Tech/Sci/R&D Officer	-

Ver el detalle de la experiencia de Gerry McKenzie.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gerry McKenzie.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Aerie Pharmaceuticals, Inc. Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX.	Health Technology
AEON Biopharma Sub, Inc. AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.	Health Technology